Activation of sodium-dependent glutamate transporters regulates the morphological aspects of oligodendrocyte maturation via signaling through calcium/calmodulin-dependent kinase IIβ's actin-binding/-stabilizing domain

GLIA

Volumn 62, Issue 9, 2014, Pages 1543-1558

  Martinez Lozada, Zila ^a,b   Waggener, Christopher T ^a   Kim, Karam ^c   Zou, Shiping ^a   Knapp, Pamela E ^a   Hayashi, Yasunori ^c,d   Ortega, Arturo ^b   Fuss, Babette ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d SAITAMA UNIVERSITY   (Japan)

Author keywords

Actin cytoskeleton; Calcium signaling; Central nervous system; Differentiation; Myelin

Indexed keywords

ACTIN; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CAMK2B PROTEIN, RAT; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; SLC1A2 PROTEIN, RAT; SLC1A3 PROTEIN, RAT; SODIUM;

ACTIN FILAMENT; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; GENETICS; INTRACELLULAR SPACE; METABOLISM; OLIGODENDROGLIA; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTIN CYTOSKELETON; ACTINS; ANIMALS; BRAIN; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; INTRACELLULAR SPACE; OLIGODENDROGLIA; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; SODIUM;

EID: 84904391571     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22699     Document Type: Article

References (105)

1. Abrahamsen B, Schneider N, Erichsen MN, Huynh TH, Fahlke C, Bunch L, Jensen AA. 2013. Allosteric modulation of an excitatory amino acid transporter: The subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain. J Neurosci 33:1068-1087.
2. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image processing with ImageJ. Biophoton Int 11:36-42.
3. Arranz AM, Hussein A, Alix JJ, Perez-Cerda F, Allcock N, Matute C, Fern R. 2008. Functional glutamate transport in rodent optic nerve axons and glia. Glia 56:1353-1367.
4. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. 1994. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
5. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
6. Bauer NG, Richter-Landsberg C, ffrench-Constant C. 2009. Role of the oligodendroglial cytoskeleton in differentiation and myelination. Glia 57:1691-1705.
7. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
8. Beart PM, O'Shea RD. 2007. Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5-17.
9. Bender AS, Woodbury DM, White HS. 1997. The rapid L- and D-aspartate uptake in cultured astrocytes. Neurochem Res 22:721-726.
10. Borgesius NZ, van Woerden GM, Buitendijk GH, Keijzer N, Jaarsma D, Hoogenraad CC, Elgersma Y. 2011. BetaCaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting alphaCaMKII to synapses. J Neurosci 31:10141-10148.
11. Boscia F, D'Avanzo C, Pannaccione A, Secondo A, Casamassa A, Formisano L, Guida N, Annunziato L. 2012. Silencing or knocking out the Na(+)/Ca(2+) exchanger-3 (NCX3) impairs oligodendrocyte differentiation. Cell Death Differ 19:562-572.
12. Bronstein JM, Hales TG, Tyndale RF, Charles AC. 1998. A conditionally immortalized glial cell line that expresses mature myelin proteins and functional GABA(A) receptors. J Neurochem 70:483-491.
13. Buttery PC, ffrench-Constant C. 1999. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 14:199-212.
14. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28:264-278.
15. Caran N, Johnson LD, Jenkins KJ, Tombes RM. 2001. Cytosolic targeting domains of gamma and delta calmodulin-dependent protein kinase II. J Biol Chem 276:42514-42519.
16. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
17. Coultrap SJ, Bayer KU. 2012. CaMKII regulation in information processing and storage. Trends Neurosci 35:607-618.
18. Dalgaard P. 2008. Introductory Statistics with R. New York: Springer.
19. D'Amelio F, Eng LF, Gibbs MA. 1990. Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system. Glia 3:335-341.
20. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65:1-105.
21. Danbolt NC, Storm-Mathisen J. 1986. Na+-dependent "binding" of D-aspartate in brain membranes is largely due to uptake into membrane-bounded saccules. J Neurochem 47:819-824.
22. Davies LP, Johnston GA. 1976. Uptake and release of D- and L-aspartate by rat brain slices. J Neurochem 26:1007-1014.
23. De Biase LM, Kang SH, Baxi EG, Fukaya M, Pucak ML, Mishina M, Calabresi PA, Bergles DE. 2011. NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci 31:12650-12662.
24. Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE. 2004. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci USA 101:7751-7756.
25. Deng W, Yue Q, Rosenberg PA, Volpe JJ, Jensen FE. 2006. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function. J Neurochem 98:213-222.
26. Dennis J, White MA, Forrest AD, Yuelling LM, Nogaroli L, Afshari FS, Fox MA, Fuss B. 2008. Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci 37:412-424.
27. DeSilva TM, Kabakov AY, Goldhoff PE, Volpe JJ, Rosenberg PA. 2009. Regulation of glutamate transport in developing rat oligodendrocytes. J Neurosci 29:7898-7908.
28. Desilva TM, Kinney HC, Borenstein NS, Trachtenberg FL, Irwin N, Volpe JJ, Rosenberg PA. 2007. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter. J Comp Neurol 501:879-890.
29. Domercq M, Etxebarria E, Perez-Samartin A, Matute C. 2005. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 52:36-46.
30. Domercq M, Matute C. 1999. Expression of glutamate transporters in the adult bovine corpus callosum. Brain Res Mol Brain Res 67:296-302.
31. Domercq M, Sanchez-Gomez MV, Areso P, Matute C. 1999. Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 11:2226-2236.
32. Emery B. 2010. Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782.
33. Erichsen MN, Huynh TH, Abrahamsen B, Bastlund JF, Bundgaard C, Monrad O, Bekker-Jensen A, Nielsen CW, Frydenvang K, Jensen AA, Bunch L. 2010. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5, 6, 7, 8-tetrahydro-4H-chrom ene-3-carbonitrile (UCPH-101). J Med Chem 53:7180-7191.
34. Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. 2008. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. J Neurosci 28:10404-10414.
35. Etxeberria A, Mangin JM, Aguirre A, Gallo V. 2010. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 13:287-289.
36. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ. 2010. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225:18-23.
37. Flores-Mendez MA, Martinez-Lozada Z, Monroy HC, Hernandez-Kelly LC, Barrera I, Ortega A. 2013. Glutamate-dependent translational control in cultured Bergmann glia cells: eIF2alpha phosphorylation. Neurochem Res 38:1324-1332.
38. Fruhbeis C, Frohlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Mobius W, Goebbels S, Nave KA, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers EM. 2013. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604.
39. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
40. Guo F, Maeda Y, Ko EM, Delgado M, Horiuchi M, Soulika A, Miers L, Burns T, Itoh T, Shen H, Lee E, Sohn J, Pleasure D. 2012. Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J Neurosci 32:639-645.
41. Hoffman L, Farley MM, Waxham MN. 2013. Calcium-calmodulin-dependent protein kinase II isoforms differentially impact the dynamics and structure of the actin cytoskeleton. Biochemistry 52:1198-1207.
42. Kanai Y, Hediger MA. 1992. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360:467-471.
43. Kim HJ, DiBernardo AB, Sloane JA, Rasband MN, Solomon D, Kosaras B, Kwak SP, Vartanian TK. 2006. WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. J Neurosci 26:5849-5859.
44. Kim K, Hayashi M, Narayanan R, Suzuki A, Matsuura K, K. O, Hayashi Y. 2011. CaMKII gates rapid structural plasticity in hippocampal dendirtic spines. Program No 87207/E3 2011. Neuroscience Meeting Planner Washington, DC: Society for Neuroscience, Online.
45. Kolodziejczyk K, Hamilton NB, Wade A, Karadottir R, Attwell D. 2009. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132:1496-1508.
46. Kolodziejczyk K, Saab AS, Nave KA, Attwell D. 2010. Why do oligodendrocyte lineage cells express glutamate receptors? F1000 Biol Rep 2:57.
47. Kredel S, Oswald F, Nienhaus K, Deuschle K, Rocker C, Wolff M, Heilker R, Nienhaus GU, Wiedenmann J. 2009. mRuby, a bright monomeric red fluorescent protein for labeling of subcellular structures. PLoS One 4:e4391.
48. Kremer D, Aktas O, Hartung HP, Kury P. 2011. The complex world of oligodendroglial differentiation inhibitors. Ann Neurol 69:602-618.
49. Kriegler S, Chiu SY. 1993. Calcium signaling of glial cells along mammalian axons. J Neurosci 13:4229-4245.
50. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749-1758.
51. Kukley M, Capetillo-Zarate E, Dietrich D. 2007. Vesicular glutamate release from axons in white matter. Nat Neurosci 10:311-320.
52. Kukley M, Nishiyama A, Dietrich D. 2010. The fate of synaptic input to NG2 glial cells: Neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells. J Neurosci 30:8320-8331.
53. Lafrenaye AD, Fuss B. 2011. Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes. J Neurochem 115:269-282.
54. Lin YC, Redmond L. 2008. CaMKIIbeta binding to stable F-actin in vivo regulates F-actin filament stability. Proc Natl Acad Sci USA 105:15791-15796.
55. Lin YC, Redmond L. 2009. Neuronal CaMKII acts as a structural kinase. Commun Integr Biol 2:40-41.
56. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
57. Lopez-Colome AM, Martinez-Lozada Z, Guillem AM, Lopez E, Ortega A. 2012. Glutamate transporter-dependent mTOR phosphorylation in Muller glia cells. ASN Neuro 4:e00095.
58. Lundgaard I, Luzhynskaya A, Stockley JH, Wang Z, Evans KA, Swire M, Volbracht K, Gautier HO, Franklin RJ, Attwell D, Káradóttir RT. 2013. Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes. PLoS Biol 11:e1001743.
59. Luyt K, Varadi A, Durant CF, Molnar E. 2006. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem 99:641-656.
60. Manders EMM, Verbeek FJ, Aten JA. 1993. Measurement of co-localization of objects in dualcolor confocal images. J Microsc 169:375-382.
61. Martinez-Lozada Z, Guillem AM, Flores-Mendez M, Hernandez-Kelly LC, Vela C, Meza E, Zepeda RC, Caba M, Rodriguez A, Ortega A. 2013. GLAST/EAAT1-induced glutamine release via SNAT3 in Bergmann glial cells: Evidence of a functional and physical coupling. J Neurochem 125:545-554.
62. Martinez-Lozada Z, Hernandez-Kelly LC, Aguilera J, Lopez-Bayghen E, Ortega A. 2011. Signaling through EAAT-1/GLAST in cultured Bergmann glia cells. Neurochem Int 59:871-879.
63. Matsugami TR, Tanemura K, Mieda M, Nakatomi R, Yamada K, Kondo T, Ogawa M, Obata K, Watanabe M, Hashikawa T, Tanaka K. 2006. From the cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc Natl Acad Sci USA 103:12161-12166.
64. Matute C. 2011. Glutamate and ATP signalling in white matter pathology. J Anat 219:53-64.
65. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
66. Okamoto K, Bosch M, Hayashi Y. 2009. The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: A potential molecular identity of a synaptic tag? Physiology 24:357-366.
67. Okamoto K, Nagai T, Miyawaki A, Hayashi Y. 2004. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat Neurosci 7:1104-1112.
68. Okamoto K, Narayanan R, Lee SH, Murata K, Hayashi Y. 2007. The role of CaMKII as an F-actin-bundling protein crucial for maintenance of dendritic spine structure. Proc Natl Acad Sci USA 104:6418-6423.
69. O'Leary H, Lasda E, Bayer KU. 2006. CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing. Mol Biol Cell 17:4656-4665.
70. Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV. 1999. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 145:1209-1218.
71. Palacin M, Estevez R, Bertran J, Zorzano A. 1998. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 78:969-1054.
72. Peghini P, Janzen J, Stoffel W. 1997. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J 16:3822-3832.
73. Peirson SN, Butler JN, Foster RG. 2003. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res 31:e73.
74. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
75. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
76. Pitt D, Nagelmeier IE, Wilson HC, Raine CS. 2003. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61:1113-1120.
77. Regan MR, Huang YH, Kim YS, Dykes-Hoberg MI, Jin L, Watkins AM, Bergles DE, Rothstein JD. 2007. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. J Neurosci 27:6607-6619.
78. Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, Bradke F, Jenne D, Holak TA, Werb Z, Sixt M, Wedlich-Soldner R. 2008. Lifeact: A versatile marker to visualize F-actin. Nat Methods 5:605-607.
79. Rodriguez A, Ortega A. 2012. The glia connection of the glutamate/glutamine shuttle. Am J Neurosci 3:32-38.
80. Rojas H, Colina C, Ramos M, Benaim G, Jaffe EH, Caputo C, DiPolo R. 2007. Na+ entry via glutamate transporter activates the reverse Na+/Ca2+ exchange and triggers Ca(i)2+-induced Ca2+ release in rat cerebellar Type-1 astrocytes. J Neurochem 100:1188-1202.
81. Rosenberg PA, Dai W, Gan XD, Ali S, Fu J, Back SA, Sanchez RM, Segal MM, Follett PL, Jensen FE, Volpe JJ. 2003. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 71:237-245.
82. Sanabria H, Swulius MT, Kolodziej SJ, Liu J, Waxham MN. 2009. {beta}CaMKII regulates actin assembly and structure. J Biol Chem 284:9770-9780.
83. Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, Seal RP, Yumoto N, Nakajima T, Amara SG. 2001. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem 79:297-302.
84. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, Nakajima T. 1998. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53:195-201.
85. Simpson PB, Holtzclaw LA, Langley DB, Russell JT. 1998. Characterization of ryanodine receptors in oligodendrocytes, type 2 astrocytes, and O-2A progenitors. J Neurosci Res 52:468-482.
86. Skokal RR, Rohlf FJ. 1995. Biometry: The principle and practice in biological research. New York: W. H. Freeman and Company.
87. Sommer I, Schachner M. 1982. Cell that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes. Neurosci Lett 29:183-188.
88. Sparrow N, Manetti ME, Bott M, Fabianac T, Petrilli A, Bates ML, Bunge MB, Lambert S, Fernandez-Valle C. 2012. The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci 32:5284-5297.
89. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. 2005. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128:1016-1025.
90. Sugiyama H, Ito I, Watanabe M. 1989. Glutamate receptor subtypes may be classified into two major categories: A study on Xenopus oocytes injected with rat brain mRNA. Neuron 3:129-132.
91. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H. 1991. The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 181:968-975.
92. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702.
93. Tansey FA, Farooq M, Cammer W. 1991. Glutamine synthetase in oligodendrocytes and astrocytes: New biochemical and immunocytochemical evidence. J Neurochem 56:266-272.
94. Trapp BD, Stys PK. 2009. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8:280-291.
95. Uwechue NM, Marx MC, Chevy Q, Billups B. 2012. Activation of glutamate transport evokes rapid glutamine release from perisynaptic astrocytes. J Physiol 590:2317-2331.
96. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C. 2006. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21:154-164.
97. van Woerden GM, Hoebeek FE, Gao Z, Nagaraja RY, Hoogenraad CC, Kushner SA, Hansel C, De Zeeuw CI, Elgersma Y. 2009. BetaCaMKII controls the direction of plasticity at parallel fiber-Purkinje cell synapses. Nat Neurosci 12:823-825.
98. Waggener CT, Dupree JL, Elgersma Y, Fuss B. 2013. CaMKIIbeta regulates oligodendrocyte maturation and CNS myelination. J Neurosci 33:10453-10458.
99. Warringa RA, van Berlo MF, Klein W, Lopes-Cardozo M. 1988. Cellular location of glutamine synthetase and lactate dehydrogenase in oligodendrocyte-enriched cultures from rat brain. J Neurochem 50:1461-1468.
100. Warrington AE, Barbarese E, Pfeiffer SE. 1993. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 34:1-13.
101. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, Hori S, Takimoto M, Wada K, Tanaka K. 1998. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur J Neurosci 10:976-988.
102. Werner P, Pitt D, Raine CS. 2001. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169-180.
103. Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP. 2004. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain 127:2636-2648.
104. Yoo AS, Krieger C, Kim SU. 1999. Process extension and intracellular Ca2+ in cultured murine oligodendrocytes. Brain Res 827:19-27.
105. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10:321-330.